146 related articles for article (PubMed ID: 19070795)
21. [Palliative care of tumors of the excretory urinary tract].
Grise P; Hacpille L
Rev Prat; 1997 Feb; 47(4):402-9. PubMed ID: 9114527
[TBL] [Abstract][Full Text] [Related]
22. [Role and technical aspects of surgery for liver metastases from urological malignancies].
Chiche L; Adam R
Prog Urol; 2008 Nov; 18 Suppl 7():S256-60. PubMed ID: 19070802
[TBL] [Abstract][Full Text] [Related]
23. Role of chemotherapy in upper urinary tract urothelial cell cancers.
Kwan A; Mazhar D
Future Oncol; 2011 Sep; 7(9):1067-75. PubMed ID: 21919694
[TBL] [Abstract][Full Text] [Related]
24. Cytoreductive nephrectomy in metastatic renal cell carcinoma: the evolving role of surgery in the era of molecular targeted therapy.
Kwan KG; Kapoor A
Curr Opin Support Palliat Care; 2009 Sep; 3(3):157-65. PubMed ID: 19528804
[TBL] [Abstract][Full Text] [Related]
25. Second-line chemotherapy for advanced urothelial cancer: because we should or because we can?
Dreicer R
J Clin Oncol; 2009 Sep; 27(27):4444-5. PubMed ID: 19687324
[No Abstract] [Full Text] [Related]
26. [Supportive care for urological metastatic patients].
Lebret T; Di Palma M; Ripoll J; Méjean A
Prog Urol; 2008 Nov; 18 Suppl 7():S410-4. PubMed ID: 19070824
[TBL] [Abstract][Full Text] [Related]
27. Treatment of metastatic renal cell carcinoma.
Reeves DJ; Liu CY
Cancer Chemother Pharmacol; 2009 Jun; 64(1):11-25. PubMed ID: 19343348
[TBL] [Abstract][Full Text] [Related]
28. Ovarian pathology in risk-reducing salpingo-oophorectomies from women with BRCA mutations, emphasizing the differential diagnosis of occult primary and metastatic carcinoma.
Rabban JT; Barnes M; Chen LM; Powell CB; Crawford B; Zaloudek CJ
Am J Surg Pathol; 2009 Aug; 33(8):1125-36. PubMed ID: 19440148
[TBL] [Abstract][Full Text] [Related]
29. [Metastastic urothelial carcinoma: is there a role for surgery?].
Lebret T; Méjean A
Prog Urol; 2008 Nov; 18 Suppl 7():S285-8. PubMed ID: 19070805
[TBL] [Abstract][Full Text] [Related]
30. Management of metastatic renal cell carcinoma: current trends.
Mohammed A; Shergill I; Little B
Expert Rev Mol Diagn; 2009 Jan; 9(1):75-83. PubMed ID: 19099350
[TBL] [Abstract][Full Text] [Related]
31. [Metastases from urothelial carcinoma : future and prospects].
Lebret T; Méjean A
Prog Urol; 2008 Nov; 18 Suppl 7():S277-84. PubMed ID: 19070804
[TBL] [Abstract][Full Text] [Related]
32. Intermittent therapy in the palliative treatment of metastatic colorectal cancer.
Wadhawan A; Stephens R; Adams R
Expert Rev Anticancer Ther; 2009 Jan; 9(1):125-34. PubMed ID: 19105712
[TBL] [Abstract][Full Text] [Related]
33. [Metastases from urologic malignancies - Report 2008 of 102e Congress of Association Française d'Urologie].
Lebret T; Méjean A
Prog Urol; 2008 Nov; 18 Suppl 7():S141-2. PubMed ID: 19070784
[No Abstract] [Full Text] [Related]
34. [Urology].
Chollet Y; Aymon D; Cardinaux C; Praz V; Tawadros T; Treuthardt C; Vaucher L; Wisard M; Zaman K; Zarkik Y; Jichlinski P
Rev Med Suisse; 2007 Jan; 3(94):168-71. PubMed ID: 17354544
[TBL] [Abstract][Full Text] [Related]
35. [Optical spectroscopy: a new approach to assess urological tumors].
Bensalah K; Fleureau J; Rolland D; Rioux-Leclercq N; Senhadji L; Lavastre O; Guillé F; Patard JJ; de Crevoisier R
Prog Urol; 2010 Jul; 20(7):477-82. PubMed ID: 20656268
[TBL] [Abstract][Full Text] [Related]
36. Radiotherapeutic treatment of metastasized urological malignancies.
van der Werf-Messing BH
Prog Clin Biol Res; 1984; 153():577-83. PubMed ID: 6473413
[No Abstract] [Full Text] [Related]
37. BK virus infection in association with posttransplant urothelial carcinoma.
Wang HH; Liu KL; Chu SH; Tian YC; Lai PC; Chiang YJ
Transplant Proc; 2009; 41(1):165-6. PubMed ID: 19249504
[TBL] [Abstract][Full Text] [Related]
38. [Role of hormonotherapy in the treatment of metastatic prostate cancer].
Lebret T; Méjean A
Prog Urol; 2008 Nov; 18 Suppl 7():S332-7. PubMed ID: 19070812
[TBL] [Abstract][Full Text] [Related]
39. Is neoadjuvant chemotherapy with gemcitabine plus cisplatin beneficial in patients with muscle-invasive bladder cancer?
Yafi FA; Kassouf W
Expert Rev Anticancer Ther; 2009 Jun; 9(6):747-52. PubMed ID: 19496711
[TBL] [Abstract][Full Text] [Related]
40. Systemic therapies for non-metastatic prostate cancer: review of the literature.
Jereczek-Fossa BA; Curigliano G; Orecchia R
Onkologie; 2009 Jun; 32(6):359-63. PubMed ID: 19521126
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
